Apoflora's independent eight-week placebo-controlled pilot study reported reduced odour in 92% of participants taking Apoflora at week 8, compared with 25% receiving placebo. The study involved 48 women aged 23–65 and assessed self-reported odour, discomfort and self-measured pH. The intervention group recorded pH around 4.5 at week 8. https://apoflora.co.uk/